WHO ICTRP trial
A study to evaluate the effectiveness of an AI-based system for identifying…
JPRN-UMIN000056645 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000056645 |
|---|---|
| Public title | A study to evaluate the effectiveness of an AI-based system for identifying hereditary breast and ovarian cancer risk, conducted in collaboration with multiple medical institutions |
| Scientific title | Evaluation of the effectiveness of an AI-Based preliminary screening system for hereditary breast and ovarian cancer (multicenter collaborative study) - Evaluation of the effectiveness of an AI-Based preliminary screening system for hereditary breast and ovarian cancer (multicenter collaborative… |
| Primary sponsor | Department of Genetic Medicine, Kanagawa Cancer Center |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Breast cancer |
| Registration date | Jun 1, 2025 |
| Target size | 200 |
| Registry page | center6.umin.ac.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: